Thrombocytopenia and clinical outcomes among patients with COVID-19 disease: A cohort study.
Hussain AlkhalifaZaenb AlsalmanAman AlfarajMohammed AlgaraashMortadah AlsalmanPublished in: Health science reports (2023)
Thrombocytopenia is a common finding among COVID-19 patients, with a predilection toward a specific group of patients, though the exact reasons are unclear. It predicts poor clinical outcomes and is closely linked to mortality, AKI, and the need for mechanical ventilation. These findings suggest that more research is required to study the mechanism of thrombocytopenia and the possibility of thrombotic microangiopathy in COVID-19 patients.
Keyphrases
- mechanical ventilation
- end stage renal disease
- sars cov
- acute respiratory distress syndrome
- ejection fraction
- intensive care unit
- newly diagnosed
- chronic kidney disease
- acute kidney injury
- peritoneal dialysis
- prognostic factors
- cardiovascular events
- density functional theory
- respiratory failure
- cardiovascular disease
- coronary artery disease
- patient reported